Sign Out
Patients who have hypersensitivity to Ibandronic acid of any ingredients contained in Ibandren 150 mg Film-Coated Tablet.
Patients with incurable hypocalcemia.
Patients who are unable to stand or sit upright for 1 hour at least.
Patients with abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia.
Patients who have genetic factor related to lactose such as galactose intolerance, Lapp lactase deficiency and glucose-galactose malabsorption.
Continue with Google